
Welcome to Dementia Matters
The Latest
November 17, 2026
Live from WRAP+: The Future of Longitudinal Observational Studies for Alzheimer’s
For 25 years, the Wisconsin Registry for Alzheimer’s Prevention (WRAP) and similar longitudinal studies have followed people over time to better understand why some individuals develop Alzheimer’s disease while others do not. As the field enters a new era of Alzheimer’s research, with FDA-approved disease-modifying treatments and advances in blood biomarkers and imaging, researchers are asking: What is the future of observational longitudinal research when we increasingly have the ability to intervene? Recorded live from the WRAP+ Conference, five experts join the podcast for a panel to discuss how these studies should evolve and more.
November 3, 2026
Why Do Clinicians Separate the Patient and Family During a Memory Evaluation?
During a memory evaluation it’s common to separate patients and their family members or care partners, which can be uncomfortable. Research professor and licensed clinical social worker Dr. Darby Morhardt joins the podcast to shed light on why clinicians might rely on loved ones to evaluate a person’s cognitive change, what they can learn from these conversations and how individuals can prepare for this evaluation.
Guest: Darby J. Morhardt, PhD, LCSW, research professor, Mesulam Center for Cognitive Neurology and Alzheimer’s Disease, Northwestern University Feinberg School of Medicine
October 20, 2026
Talking about Memory Tests and Cognitive Screenings for Dementia
When a person goes through memory testing, what does that actually mean and what can they expect to learn from their results? Returning guest Dr. Tori Williams joins the podcast to discuss what cognitive screenings and tests are, the benefits of early and repeat memory testing and more.
Guest: Victoria Williams, PhD, neuropsychologist, UW Health, associate professor, Department of Medicine, University of Wisconsin School of Medicine and Public Health
October 6, 2026
Looking at More than Memory: Functional Assessments and Blood Tests for Alzheimer’s Disease in Primary Care
Though new blood-based biomarker tests have made it less expensive, less invasive and more accessible to diagnose Alzheimer’s disease, they can’t replace the diagnostic process as a whole. Dr. Eric Widera joins the podcast to discuss the importance of assessing function when making a dementia diagnosis, what functional change can look like and how this kind of assessment can be incorporated into primary care practice, as well as debate how Alzheimer’s disease blood tests should be used in primary care.
Guest: Eric Widera, MD, professor of medicine, clinician-educator, Division of Geriatrics, University of California San Francisco (UCSF), director, Chief of Geriatrics, Palliative and Extended Care, medical director, Hospice & Palliative Care Service, San Francisco VA Health Care System, co-founder, GeriPal podcast, co-founder, ePrognosis
Listen and learn about a particular topic

Interested in research? Connect with one of our affiliates!
Get Involved
Find ways to get involved with research, contact us, or make a gift to our program!


